Csaba Bödör obtained his PhD degree from molecular oncology at Semmelweis University in 2008. He developed interest in molecular pathogenesis of hematological malignancies. He spent three years in Barts Cancer Institute (London, UK) with a postdoctoral research fellowship from the European Hematology Association (EHA). After his return to Hungary he developed a research program on genomic and epigenetic background of B-cell lymphomas and familial myeloid malignancies. Currently, he is the head of the molecular diagnostics unit and the molecular oncohematology research group at the Department of Pathology and Experimental Cancer Research, Semmelweis University
